New diagnostic criteria published
A new set of clinical guidelines for the diagnosis of PSP has been published in the journal “Movement Disorders”.
The guidelines were developed by an international team of leading PSP experts, including PROSPECT principal investigators Prof Huw Morris and Prof James Rowe. Thanks to your generous support, we were able to contribute to the funding of this special task force for their extensive review of the literature and analysis of patient data.
The new guidelines will support neurologists in diagnosing the condition at an earlier stage and will help ensure that a wider range of symptom patterns will be recognised as PSP, reflecting the relatively recent discoveries of various subtypes of the disease. This means that more people with PSP should get quicker access to the most appropriate care and support. They could also be eligible to take part in future clinical trials, which generally demand that participants are in the early stages of the condition to give the trial drug the best chance of working.
Although the new diagnostic criteria are more complex, the expert task force believe that they should only take an experienced neurologist around 15 minutes to work through, and a web-based tool is currently in development to enable widespread implementation.